Sign in
4

Changes in Ownership

Perspective Therapeutics, Inc. Filed Acc 0001437749-20-021849

Director bought 20,000 shares at $0.52 ($10,400)

From the SEC's structured data for this filing

Trades in this filing

Vitale Philip J · Director

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2020-10-22 Purchase : show line 1 in the form +20,000 $0.52 $10,400 130,000 I
Open-market purchases · 20,000 sh · avg $0.52 · $10,400

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-10-22 Purchase : show line 2 in the form Warrant (right to buy) +10,000 155,000 I
Loading xslF345X03/rdgdoc.xml…